Mass General Program to Help Doctors Balance End-of-Life Talks With Precision Oncology Optimism

High expectations for targeted therapies make metastatic lung cancer patients hopeful, but they need support once they progress or run out of targeted therapy options.

Related Keywords

Massachusetts ,United States ,Laura Petrillo ,National Cancer Institute ,Drug Administration ,Massachusetts General Hospital ,Mass General ,Takeda Pharmaceutical ,